Analysis of peripheral blood from AD individuals showed a significantly higher methylation ratio in the brain-derived neurotrophic factor (BDNF) promoter compared to the control, with a negative correlation with neuropsychological test subscores indicating the influence in AD manifestation [69,70]. This evidence concerns the gene BDNF and Alzheimer disease.